Navigation Links
X-ray diffraction may play key role in stopping 'kissing bug,' fungus
Date:10/19/2010

COLUMBIA, Mo. If finding the cure for a fungus and parasite that affects millions of people were the subject of a detective show, University of Missouri Chemistry Professor John Tanner would be the forensic expert in the lab, using high-tech equipment to make a model that could eventually solve the crime.

Tanner, who also teaches chemistry in the College of Arts and Science, has joined forces with Pablo Sobrado, an assistant professor of biochemistry at Virginia Tech, to study a unique enzyme found on two "crime scenes": in Aspergillus fumigatus, a fungus that causes pulmonary diseases in immuno-compromised people; and in a blood-sucking insect prevalent in South America and now being found in the southwestern U.S., called the Chagas parasite, also known as the "kissing bug" for the red welts left on the victims' faces after being bitten in his or her sleep.

"My job is to figure out what the enzyme looks like using X-ray diffraction," Tanner said. "This enzyme makes a special sugar molecule that these organisms need to survive, so if we can find a way to stop the reaction that makes that sugar, then we might find a way to kill these pathogens."

In Tanner's lab at the University of Missouri, researcher Dale Karr is in the first stages of the process growing tiny crystals of the enzyme. These crystals will eventually be used in X-ray crystallography, a technique in which diffraction patterns that are produced by bombarding crystals with intense X-ray beams are decoded to determine the atomic structure of the enzyme. With this information, and Sobrado's information on how the protein can be isolated and characterized, different drugs that may inhibit the enzyme can be designed and tested.

"The enzyme is like a lock, and if we can see what the lock looks like, we can find a key to fit in the lock and prevent the enzyme from being active," said Tanner. "This is interesting because it's a new project for us, and the collaboration with Pablo has enabled my group to enter a different field with a focus on drug design. That's exciting for me; hopefully the fruits of our labor will some day help people."

The National Institutes of Health (NIH) has given a $1.5 million grant to support the five-year research project.


'/>"/>

Contact: Steven Adams
AdamsST@missouri.edu
573-882-8353
University of Missouri-Columbia
Source:Eurekalert

Related biology news :

1. An X-ray for your genes
2. LiXEdrom: Innovative measuring chamber for X-ray study of liquid jets
3. Early results from the worlds brightest X-ray source
4. First X-ray lasers early success brings approval for next-phase facility
5. Lensless imaging of whole biological cells with soft X-rays
6. E-beam and X-ray irradiation technologies
7. Scientists using X-ray vision to produce more nutritious flour
8. Researchers demonstrate nanoscale X-ray imaging of bacterial cells
9. Scientists make important step toward stopping plaque-like formations in Huntingtons disease
10. Mango effective in preventing, stopping certain colon, breast cancer cells
11. Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... 12, 2017  Trovagene, Inc. (NASDAQ: TROV ... today announced that it has signed agreements with seven ... the Middle East for commercialization ... the first wave of international distribution agreements for Trovagene,s ... samples. The initial partners will introduce Trovagene,s ...
(Date:1/6/2017)... Jan. 6, 2017  Privately-held CalciMedica, Inc., announced ... healthy volunteers of a novel calcium release-activated calcium ... pancreatitis. Acute pancreatitis, sudden painful ... disorder, but can be very serious.  In severe cases ... where extended hospital stays, time in the ICU ...
(Date:1/3/2017)... , Jan. 3, 2017 Onitor, provider of ... of Onitor Track, an innovative biometric data-driven program designed ... this month at the 2017 Consumer Electronics Show (CES) ... In the U.S., the World Health Organization (WHO), ... two-thirds of adults who are overweight or obese. WHO ...
Breaking Biology News(10 mins):
(Date:1/20/2017)... 2017 http://www.Financialbuzz.com - ... leading causes of death worldwide. There were 8.2 million ... cancer related deaths increased gradually over time, the death ... of various cancers continues to drive demand of biological ... Global Market Insights, Inc. cancer biological therapy market size was ...
(Date:1/19/2017)... Jan. 19, 2017 /PRNewswire -- WuXi AppTec, a ... capability and technology platform, today announced that it ... focused preclinical drug discovery contract research organization (CRO). ... a wholly-owned subsidiary of WuXi, and will continue ... providing greater services. The acquisition will further strengthen ...
(Date:1/19/2017)... Calif. , Jan. 19, 2017  ArmaGen, ... Mathias Schmidt , Ph.D., as chief executive officer, ... of directors. Dr. Schmidt brings to ArmaGen more than ... the research and development of biotherapeutics and pharmaceuticals. ... executive with the diverse experience and skillset necessary ...
(Date:1/19/2017)... ... January 19, 2017 , ... DaVita Clinical Research ... drug and device development, and Prism Clinical Research , a leader in ... Verified Clinical Trials (VCT) has been selected by both companies as ...
Breaking Biology Technology: